| # | Title | Journal | Year | Citations |
|---|
| 1 | Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle> | JAMA - Journal of the American Medical Association | 2009 | 1,409 |
| 2 | Current micropump technologies and their biomedical applications | Microsystem Technologies | 2009 | 278 |
| 3 | Discovery and mechanism of ustekinumab | MAbs | 2011 | 246 |
| 4 | Characterisation of drug release from cubosomes using the pressure ultrafiltration method | International Journal of Pharmaceutics | 2003 | 221 |
| 5 | Monitored Anesthesia Care with Dexmedetomidine: A Prospective, Randomized, Double-Blind, Multicenter Trial | Anesthesia and Analgesia | 2010 | 221 |
| 6 | The SAGE Guideline Model: Achievements and Overview | Journal of the American Medical Informatics Association: JAMIA | 2007 | 165 |
| 7 | Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review | Nanoscale | 2015 | 127 |
| 8 | A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit* | Critical Care Medicine | 2010 | 119 |
| 9 | Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems | BioMed Research International | 2014 | 116 |
| 10 | Preformulation studies of myricetin: a natural antioxidant flavonoid | Die Pharmazie | 2014 | 85 |
| 11 | Biosimilars: Impact of Biologic Product Life Cycle and European Experience on the Regulatory Trajectory in the United States | Clinical Therapeutics | 2012 | 65 |
| 12 | Quantitative Determination of Myricetin in Rat Plasma by Ultra Performance Liquid Chromatography Tandem Mass Spectrometry and its Absolute Bioavailability | Drug Research | 2014 | 54 |
| 13 | Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies | European Journal of Pharmaceutics and Biopharmaceutics | 2013 | 51 |
| 14 | Cell therapy medical tourism: Time for action | Cytotherapy | 2010 | 42 |
| 15 | Phytantriol-Based In Situ Liquid Crystals with Long-Term Release for Intra-articular Administration | AAPS PharmSciTech | 2015 | 42 |
| 16 | Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. | Fìtoterapìâ | 2014 | 35 |
| 17 | Switching epoetin alfa and epoetin zeta in patients with Renal Anemia on Dialysis: Posthoc analysis | Advances in Therapy | 2010 | 33 |
| 18 | CFD-DEM simulation of fluidization of multisphere- modelled cylindrical particles | Powder Technology | 2020 | 28 |
| 19 | The Effect of Parenterally Administered Cyclodextrins on the Pharmacokinetics of Coadministered Drugs | Journal of Pharmaceutical Sciences | 2012 | 23 |
| 20 | Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits | Pharmaceutical Development and Technology | 2016 | 16 |
| 21 | CFD-DEM -DDM Model for Spray Coating Process in a Wurster Coater | Journal of Pharmaceutical Sciences | 2020 | 14 |
| 22 | Investigation of Drug Delivery by Iontophoresis in a Surgical Wound Utilizing Microdialysis | Pharmaceutical Research | 2008 | 12 |
| 23 | Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions | Antimicrobial Agents and Chemotherapy | 2021 | 12 |
| 24 | Postoperative opioid sparing with injectable hydroxypropyl-β-cyclodextrin-diclofenac: pooled analysis of data from two Phase III clinical trials | Journal of Pain Research | 2017 | 9 |
| 25 | A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration | European Journal of Drug Metabolism and Pharmacokinetics | 2016 | 9 |
| 26 | Redox proteomic investigation of tetracycline‐induced steatosis | Proteomics | 2015 | 3 |
| 27 | Capturing particle-particle interactions for cylindrical fibrous particles in different flow regimes | Powder Technology | 2018 | 3 |
| 28 | FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs | Clinical Infectious Diseases | 2021 | 3 |
| 29 | Software reliability allocation with safety concerns in medical devices | | 2012 | 2 |
| 30 | Driving transformational change: lessons for boards and leaders | Trustee | 2010 | 2 |
| 31 | A changing time: the International Society for Cellular Therapy embraces its industry members | Cytotherapy | 2010 | 1 |
| 32 | Electrochemical Assessment of Sequence Selective DNA Damage from Myoglogin and Cytochrome P450 Bioactivated Benzo[a]pyrene at TP53 Oligomers | Electroanalysis | 2016 | 1 |
| 33 | US database study: burden and healthcare resource utilization in adults with systemic endemic mycoses and aspergillosis | Journal of Comparative Effectiveness Research | 2020 | 1 |
| 34 | Use software reliability growth models wisely | | 2013 | 0 |
| 35 | 1354. Novel Formulation SUBA-Itraconazole in Fed and Fasted Healthy Volunteers: Expanding the Clinical Utility of the Established Mold Active Agent | Open Forum Infectious Diseases | 2018 | 0 |
| 36 | Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris | SKIN the Journal of Cutaneous Medicine | 0 | 0 |
| 37 | A multicenter, open label, Phase 1 study of the safety, tolerability, systemic exposure, pharmacodynamics, and treatment effect of calcipotriene foam, 0.005% in pediatric subjects (ages 2 to 11 years) with plaque psoriasis. | SKIN the Journal of Cutaneous Medicine | 0 | 0 |
| 38 | Real World Patient Perceptions of the use of Calcipotriene Foam 0.005% in the Treatment of Plaque Psoriasis | SKIN the Journal of Cutaneous Medicine | 0 | 0 |
| 39 | The board's role in technology advancement | Trustee | 2009 | 0 |
| 40 | Clearing the pathway. Health care leaders are working to bring gender parity to the C-suite and board room | Trustee | 2011 | 0 |
| 41 | Leadership succession planning: a governance imperative | Trustee | 2013 | 0 |
